Kossan

Kossan | Joined since 2020-08-23

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

0

Threads

303

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
303
Past 30 days
0
Past 7 days
0
Today
0

User Comments
Stock

2021-01-29 08:40 | Report Abuse

Shorties Losses on GameStop short positions in U.S. firms top $70 billion.. buy Kossan today if you want to revenge!

Stock

2021-01-29 08:39 | Report Abuse

Shorties Losses on GameStop short positions in U.S. firms top $70 billion.. buy Hartalega if you want to revenge!

Stock

2021-01-29 08:32 | Report Abuse

Ok guys, this is from Reddit forum. Let’s everyone buy 10k once open. Show them what the retailers have.

Thank you /r/wallstreetbets

Yo you have lit the world of financials on fire with GME.

You've broken down every single financial model and decided to take things into your own hands. And you've inspired us to bring our market back into our control.

Well done! We here in Malaysia have been exporting nearly 65% of all gloves in the world and our glove companies are reaching for the stars in profits every quarter. However, our markets might beunder complete domination and supression, that might be manipulating the public media to any way they see fit and to collect shares at the cheapest possible prices. All while causing domino effects of panic selling. Our own people are terrified to invest into our highest performing industry because of constant manipulation. Glove companies like Topglove, Supermax, Hartalega, Kossan , Comfort, Care Plus and a few more other smaller glove producers are now all trading at criminally low PE of less than 15 and forward PE of single digits despite earning record breaking profits because of the pandemic.

Stock

2021-01-29 08:32 | Report Abuse

Ok guys, this is from Reddit forum. Let’s everyone buy 10k once open. Show them what the retailers have.

Thank you /r/wallstreetbets

Yo you have lit the world of financials on fire with GME.

You've broken down every single financial model and decided to take things into your own hands. And you've inspired us to bring our market back into our control.

Well done! We here in Malaysia have been exporting nearly 65% of all gloves in the world and our glove companies are reaching for the stars in profits every quarter. However, our markets might beunder complete domination and supression, that might be manipulating the public media to any way they see fit and to collect shares at the cheapest possible prices. All while causing domino effects of panic selling. Our own people are terrified to invest into our highest performing industry because of constant manipulation. Glove companies like Topglove, Supermax, Hartalega, Kossan , Comfort, Care Plus and a few more other smaller glove producers are now all trading at criminally low PE of less than 15 and forward PE of single digits despite earning record breaking profits because of the pandemic.

Are they perfect? No, everyone can improve their processes, even if they're highly profitable. We are aware of the controversies, let's hold them accountable and ask for improvement.

Are their products saving lives? Yes, imagine how many lives have been saved just from the usage of gloves. They deserve criticism and a chance to improve, not to be supressed like this.

#gloveisgold

- A certain big investment bank has put a target price of 80usd cents per share for Topglove, who earned half a billion usd in profit after tax in one quarter!
- Every time a record breaking quarterly result is released, all glove prices crash, predictably, every single time. Hartalega earned 1 billion in MYR PAT last qr, and it dropped 5% the next day.
- All gloves are on overall downtrend for months now despite breaking records and outperforming every single sector in our country.

We're gonna be fighting in our markets tomorrow, and I want to thank you so much for inspiring us to do it. We retailers are the market. Good luck with your fight, I'm cheering you on!

If you guys wanna help us Malaysians, please spread awareness by sharing my message and upvoting:

"I want to share a message to pump our people up. Our glove companies, with whatever imperfections they have, are our national treasure. No matter what institutes might do to make you think less of them, they are our pride. To naysay them, to say that after covid is over, our gloves are gonna die. All of that is just unpatriotic and untrue. We should be proud of what we have, supporting them fully to reach the next level, fixing their problems, criticizing them fairly for their issues, and help them grow bigger. How terrible that when Topglove challenged to become a Fortune 500 and pass Maybank (An investment bank) in market cap, we saw what happened. Rampant media and price manipulation is undeniable. Our local hero wants to become a Fortune 500, and people are naysaying that. What do we hope from our successes here? For them to fail? We reward our success with manipulation, single digit PE, and with splitting opinions with some hoping they and their investors lose money. It's terrible. Something big has happened in America, something that shows that the institution and the big money are at our mercy. I believe in that now.

I want this to change. Whoever is still holding gloves have already been through hell, join me by saying eff you to investment banks, fund managers, market manipulators, and everyone else. We are retailers, this is our market. Let our winners be winners. I'm not selling and I'm gonna buy more when the market opens tomorrow. I'm not gonna swim with the waves they decide. I will be holding. I believe in gloves strongly and it deserves a fair valuation. #gloveisgold

HOLD. "

> 我想分享一个信息,以激励我们的人民。我们的手套公司,无论他们有什么不完善之处,都是我们的国宝。无论投资机构采取什么措施使您减少对它们的想法, 它们都是我们的骄傲。
> 对于不看好的人,说在covid结束之后,我们的手套公司将会死掉,所有这些都是不爱国和不真实的。
> 我们应该为自己拥有的东西感到自豪,全力支持他们成长达到下一个层次,解决他们的问题,公平地批评他们,当Topglove挑战成为财富500强并超越市值的马来亚银行(Maybank)时,我们看到了所发生的一切,媒体和价格操纵猖的发生是不可否认的。
> 本地企业努力想要成为财富500强,却遭到媒体和操纵者对此激烈反对。难道我们不希望他们在这里取得成功吗?让他们失败吗?
> 我们通过操纵,强压股价甚至到个位数的PE,以及以不同的观点来煽动,并希望他们和他们的投资者亏钱。太可怕了!
> 美国发生了大事,这也让我们知道,机构和巨额资金可以由我们控制摆布。从未发生,但我现在相信我们可以。
>
> 我想要改变。任何还拥有手套的投资者,谁都已经陷入困境!请加入我们的行列,向投资银行,基金经理,市场操纵者和其他所有人道歉。我们是零售投资者,这是我们的市场。让我们的赢家成为赢家。明天市场开盘时,我不卖出我的股票,我会买更多。我不会跟着他们决定的市场情绪影响着我。我将会持续守着不卖出让他们得逞。我坚信手套股,应该给予合理的估值。 #gloveisgold



I am not a financial expert, I am merely sharing my opinion and this is not a call to buy or sell. I do not believe we can do what happened with GME, I just want our market to recognize the value of our gloves.

Please read this and educate yourself: https://www.davemanuel.com/investor-dictionary/gamma-squeeze/

Stock

2021-01-29 00:02 | Report Abuse

To all Glove believers. Please join this reddit group and punish shorties tomorrow. Proven in Wallstreet

https://www.malaymail.com/news/malaysia/2021/01/28/inspired-by-gamestop-surge-bursabets-starts-drive-for-local-glovemakers-sha/1944916

Stock
Stock

2021-01-25 16:07 | Report Abuse

Insider news - kossan profit went up triple Is true

Stock

2021-01-22 12:08 | Report Abuse

Glove counters shooting up to the roof today due to unprecedented death- post vaccine. This time it happened in France

https://www.connexionfrance.com/French-news/Five-deaths-in-France-reported-after-Covid-Pfizer-BioNTech-vaccination

Stock

2021-01-19 14:57 | Report Abuse

23 Deaths In Norway, 10 In Germany, Shortly After The COVID Vaccination, A Coincidence?

https://m.youtube.com/watch?v=2Bicw9IKC5o

Stock

2021-01-19 08:12 | Report Abuse

Breaking news!

1st post-vaccination death reported in India. A 46-year-old attendant at a public hospital in northern India died Monday shortly after being vaccinated against the novel coronavirus.

In the first such fatality since the country launched its mass vaccination campaign on Saturday, Mahipal Singh reported breathlessness and unease in the chest before he died within 24 hours of receiving a dose of the Covishield vaccine manufactured by Serum Institute of India and developed by Oxford University and AstraZeneca.

https://www.aa.com.tr/en/asia-pacific/1st-post-vaccination-death-reported-in-india/2113690

Stock

2021-01-18 22:36 | Report Abuse

Does anyone trust Pfizer vaccine? There were the first to have rolled out the vaccine, the CEO dumped the share after the announcement, the CEO refused to be vaccinated and now...Autopsies showed that the recipients of the vaccine suffered fever, purging and nausea which are normal adverse reactions after receiving immunisation.

https://www.malaymail.com/news/malaysia/2021/01/18/health-minister-more-research-to-be-conducted-on-pfizer-biontech-covid-19-v/1941685

Stock

2021-01-18 15:53 | Report Abuse

So you know why Kossan and glove counters are on rising trend?
Something fishy: Pfizer CEO not jabbing himself with Pfizer vaccine raises big questions

https://www.news18.com/amp/news/buzz/something-fishy-pfizer-ceo-not-getting-his-own-companys-covid-19-vaccine-raises-questions-3182408.html

Stock

2021-01-18 14:41 | Report Abuse

To all short sellers. Please read below from The Edge

Looking ahead, the group noted the exponential growth in demand for personal protective equipment due to the pandemic and said demand continues to exceed supply in its gloves division.

“The increase in average selling price has started to be reflected in the current quarter, and the group expects further significant upward price adjustments on a quarter-on-quarter basis in 4QFY20,” said the group.

Stock

2021-01-18 14:38 | Report Abuse

From the Edge

In its filing with the bourse, Kossan said it saw improvements in all three of its divisions, namely the gloves, technical rubber products (TRP) and cleanroom business segments.

The gloves division achieved 671% growth in pre-tax profit to RM416.65 million.

The TRP division recorded a 19% increase in pre-tax profit, as the division had resumed full operations since the lockdown imposed under the Movement Control Order (MCO), while also seeing a rebound in deliveries in the infrastructure segment.

The cleanroom division’s pre-tax profit soared 1,132% to RM10.19 million, as demand for the division’s products increased as a result of the Covid-19 pandemic.

Stock

2021-01-16 08:59 | Report Abuse

Fresh From CDC

CDC has issued updated interim clinical considerations for use of mRNA COVID-19 vaccines currently authorized in the United States 5)

https://www.cdc.gov/mmwr/volumes/70/wr/mm7002e1.htm

Stock

2021-01-16 00:43 | Report Abuse

Fresh

Chinese health experts call to suspend Pfizer's mRNA vaccine for elderly after Norwegian deaths

https://www.globaltimes.cn/page/202101/1212915.shtml

Stock

2021-01-16 00:41 | Report Abuse

Fresh from CNA

New mutations raise concern on Vaccine effectiveness

Stock

2021-01-14 20:52 | Report Abuse

Moderna CEO says the world will have to live with Covid 'forever'

Stock

2021-01-07 23:09 | Report Abuse

Death of Florida doctor after receiving COVID-19 vaccine under investigation https://www.google.com.my/amp/s/amp.usatoday.com/amp/6574414002

Stock

2021-01-06 09:00 | Report Abuse

RIP for those who didn’t buy this year

Just in from google news

Portuguese nurse dies two days after getting the Pfizer Covid vaccine

Stock

2021-01-05 18:32 | Report Abuse

No vaccine for HIV after 40 years of research.
No vaccine for common flu after 70 years of research.
No cure for cancer after 100 years of research.
A virus mysteriously appears and in less than a year a vaccine is created and we are all expected to take it.
MODerNA... modified dna.
GMO. GMH - Genetically Modified Humans.
first they Modified/engineered plants, fruits, vegetables, ... then animals, ... Now HUMANS, ...

Stock

2021-01-05 18:31 | Report Abuse

Fresh from CNA correspondence

The coming COVID-19 vaccine will permanently alter our genetics, and the second dose contains Luciferase and Luciferin. GMO genetically modified organisms is man changing the DNA of fruits and vegetables and animals.

No vaccine for HIV after 40 years of research.
No vaccine for common flu after 70 years of research.
No cure for cancer after 100 years of research.
A virus mysteriously appears and in less than a year a vaccine is created and we are all expected to take it.
MODerNA... modified dna.
GMO. GMH - Genetically Modified Humans.
first they Modified/engineered plants, fruits, vegetables, ... then animals, ... Now HUMANS, .

Stock

2020-12-28 00:46 | Report Abuse

Fresh from the Edge

Insas failed to raise up to RM133m via renounceable rights issue to repay loans

Stock

2020-12-15 15:41 | Report Abuse

Fresh from CNN

Doctors: After initial concern,?

We still don't know the long-term efficacy of the vaccine. Will we need to be vaccinated again in the following year? Perhaps, but right now, we need whatever protection the vaccine can afford us to get on top of the pandemic. And even if the vaccines' effectiveness falls short of the current estimates, the new Covid-19 vaccines promise to be far more effective than most years' flu vaccines.

Stock

2020-12-15 15:38 | Report Abuse

Fresh from RHB research

RHB Retail Research said Kossan Rubber Industries Bhd may rise higher after it breached above the RM4.80 threshold.

“Towards the upside, the immediate resistance is at the RM5.49 level, followed by the RM5.80 threshold,” it said.

Stock

2020-12-14 12:54 | Report Abuse

Fresh from McKinsey

McKinsey has reinstated coverage of Top Glove Corp Bhd, with a Buy recommendation and a fair value of RM9.50 — as it sees the development of a new growth cycle for glove makers, in anticipation of a huge undersupply in the market, as glove demand accelerates in tandem with the rapid pace of testing for Covid-19.

Besides the world's largest rubber glove maker, it also initiated coverage of its closest peers Hartalega Holdings Bhd and Kossan Rubber Industries Bhd, also with Buy ratings.

It gave a fair value of RM26.50 for Hartalega, and a fair value of RM12.80 to Kossan.

Stock

2020-12-14 12:48 | Report Abuse

Fresh from Maybank

Maybank Investment Bank (IB) Research analyst Lee Yen Ling said in a report today she expects all glove players to report stronger earnings for the fourth quarter of 2020 (4Q20) and 1Q21 on average selling price (ASP) hikes, which would be more than enough to offset raw material cost increases as well as a weaker US dollar against the ringgit.

She maintained her "buy" calls for Hartalega, Kossan and Top Glove, with respective target prices (TPs) of RM20.60, RM10.05 and RM8.65.

Stock

2020-12-11 09:47 | Report Abuse

Fresh from Kenanga

Kenanga Research has reiterated its “outperform” call for Kossan Bhd with a higher target price (TP) of RM14, from RM 10.50 previously, based on 21.5 times calendar year 2021 estimated (CY21E) earnings per share (EPS) of 85.3 sen.

In a note today, Kenanga analyst Raymond Choo said this was lower than its previous price-earnings ratio (PER) of 21 times as he believes the valuations are pegged to supernormal earnings, and the upside to peak earnings should have been factored in.

However, he also raised the glove maker’s estimated net profit for the financial year ending Aug 31, 2020 (FY20E) and FY21E by 16% and 120% respectively to RM1 billion and RM 2 billion, resulting in higher EPS of 38 sen and 100.4 sen.

Stock

2020-12-11 01:10 | Report Abuse

Fresh from Reuters

Brazil’s health regulator has suspended the large, late-stage trial of an experimental Covid-19 vaccine by Chinese developer Sinovac following the death of a volunteer. In a statement on Thursday, national health surveillance agency Anvisa said “a severe adverse event” had occurred on without further elaboration. “The agency decided to suspend the study to evaluate the data observed so far and judge the risk and benefit of continuing the study,” it said.

Stock

2020-12-08 00:13 | Report Abuse

Macquarie Equities Research (MQ Research) summarised a presentation held by the Kossan’s Executive Director in the ASEAN Conference. Strong glove demand is reaffirmed as enquiries for spot orders continue to rise with Kossan’s observation of a shortage in the market currently. Kossan shared its plan to increase the average selling price (ASP) and spot prices in December and November while sharing its view of that an oversupply may not be likely to happen in 2021 despite having a lot of new entrants into the sector. MQ Research maintains Kossan’s target price at RM30.40.
Read on for more.

Stock

2020-12-07 08:17 | Report Abuse

Fresh from CNBC

Dr. Anthony Fauci says there's a chance coronavirus vaccine may not provide immunity for very long.

White House health advisor Dr. Anthony Fauci said he worries about the "durability" of a potential coronavirus vaccine, saying there's a chance it may not provide long-term immunity.
If Covid-19 acts like other coronaviruses, "it likely isn't going to be a long duration of immunity," Fauci, director of the National Institute of Allergy and Infectious Diseases, told JAMA Editor Howard Bauchner.